Rheumatiod Arthritis: An Updated Overview of Latest Therapy and Drug Delivery
Rheumatoid arthritis is a severe autoimmune disorder, related to joints. It is associated with serious cartilage destruction. This causes disability and reduces the excellence of life. Numerous treatments are existed to combat this disease, however, they are not very efficient and possess severe sid...
Main Authors: | Disha Kesharwani, Rishi Paliwal, Trilochan Satapathy, Swarnali Das Paul |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Pharmacopuncture Institute
2019-12-01
|
Series: | Journal of Pharmacopuncture |
Subjects: | |
Online Access: | http://www.journal-pharm.com/sub/view/300 |
Similar Items
-
Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study
by: Ryoki Hara, et al.
Published: (2019-04-01) -
Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors, tocilizumab, or abatacept in osteoporosis with rheumatoid arthritis
by: Suzuki T, et al.
Published: (2018-03-01) -
Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registry
by: Denis Choquette, et al.
Published: (2019-06-01) -
Abatacept and cardiovascular risk in rheumatoid arthritis: update
by: T. V. Popkova
Published: (2018-01-01) -
Rituximab for the treatment of rheumatiod arthritis patients with failure to the first biologic drug: Impact on Republic fund for health insurance in Serbia
by: Janković Slobodan M.
Published: (2013-01-01)